85 related articles for article (PubMed ID: 22186784)
21. APPL proteins promote TGFβ-induced nuclear transport of the TGFβ type I receptor intracellular domain.
Song J; Mu Y; Li C; Bergh A; Miaczynska M; Heldin CH; Landström M
Oncotarget; 2016 Jan; 7(1):279-92. PubMed ID: 26583432
[TBL] [Abstract][Full Text] [Related]
22. The inhibitory effects of transforming growth factor beta1 on breast cancer cell proliferation are mediated through regulation of aberrant nuclear factor-kappaB/Rel expression.
Sovak MA; Arsura M; Zanieski G; Kavanagh KT; Sonenshein GE
Cell Growth Differ; 1999 Aug; 10(8):537-44. PubMed ID: 10470853
[TBL] [Abstract][Full Text] [Related]
23. Antiestrogens induce transforming growth factor beta-mediated immunosuppression in breast cancer.
Joffroy CM; Buck MB; Stope MB; Popp SL; Pfizenmaier K; Knabbe C
Cancer Res; 2010 Feb; 70(4):1314-22. PubMed ID: 20145137
[TBL] [Abstract][Full Text] [Related]
24. c-Myb associates with PML in nuclear bodies in hematopoietic cells.
Dahle Ø; Bakke O; Gabrielsen OS
Exp Cell Res; 2004 Jul; 297(1):118-26. PubMed ID: 15194430
[TBL] [Abstract][Full Text] [Related]
25. The Expression of c-Myb Correlates with the Levels of Rhabdomyosarcoma-specific Marker Myogenin.
Kaspar P; Zikova M; Bartunek P; Sterba J; Strnad H; Kren L; Sedlacek R
Sci Rep; 2015 Oct; 5():15090. PubMed ID: 26462877
[TBL] [Abstract][Full Text] [Related]
26. Apoptotic Cancer Cells Suppress 5-Lipoxygenase in Tumor-Associated Macrophages.
Ringleb J; Strack E; Angioni C; Geisslinger G; Steinhilber D; Weigert A; Brüne B
J Immunol; 2018 Jan; 200(2):857-868. PubMed ID: 29229677
[TBL] [Abstract][Full Text] [Related]
27. C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells.
Gomis RR; Alarcón C; Nadal C; Van Poznak C; Massagué J
Cancer Cell; 2006 Sep; 10(3):203-14. PubMed ID: 16959612
[TBL] [Abstract][Full Text] [Related]
28. Strong association between c-myb and oestrogen-receptor expression in human breast cancer.
Guérin M; Sheng ZM; Andrieu N; Riou G
Oncogene; 1990 Jan; 5(1):131-5. PubMed ID: 2181374
[TBL] [Abstract][Full Text] [Related]
29. Collagen loss and impaired wound healing is associated with c-Myb deficiency.
Kopecki Z; Luchetti MM; Adams DH; Strudwick X; Mantamadiotis T; Stoppacciaro A; Gabrielli A; Ramsay RG; Cowin AJ
J Pathol; 2007 Feb; 211(3):351-61. PubMed ID: 17152050
[TBL] [Abstract][Full Text] [Related]
30. C-myc overexpression, c-mil, c-myb expression in a breast tumor cell line. Effects of estrogen and antiestrogen.
Collyn-d'Hooghe M; Vandewalle B; Hornez L; Lantoine D; Revillion F; Lefebvre J; Kerckaert JP
Anticancer Res; 1991; 11(6):2175-9. PubMed ID: 1776859
[TBL] [Abstract][Full Text] [Related]
31. MYC Is a Crucial Mediator of TGFβ-Induced Invasion in Basal Breast Cancer.
Cichon MA; Moruzzi ME; Shqau TA; Miller E; Mehner C; Ethier SP; Copland JA; Radisky ES; Radisky DC
Cancer Res; 2016 Jun; 76(12):3520-30. PubMed ID: 27197167
[TBL] [Abstract][Full Text] [Related]
32. Silencing of the annexin II gene down-regulates the levels of S100A10, c-Myc, and plasmin and inhibits breast cancer cell proliferation and invasion.
Zhang J; Guo B; Zhang Y; Cao J; Chen T
Saudi Med J; 2010 Apr; 31(4):374-81. PubMed ID: 20383413
[TBL] [Abstract][Full Text] [Related]
33. The regulation of apoptosis by activin and transforming growth factor-beta in early neoplastic and tumorigenic ovarian surface epithelium.
Choi KC; Kang SK; Tai CJ; Auersperg N; Leung PC
J Clin Endocrinol Metab; 2001 May; 86(5):2125-35. PubMed ID: 11344217
[TBL] [Abstract][Full Text] [Related]
34. The carbonic anhydrase I locus contains a c-Myb target promoter and modulates differentiation of murine erythroleukemia cells.
Chen J; Kremer CS; Bender TP
Oncogene; 2006 May; 25(19):2758-72. PubMed ID: 16407849
[TBL] [Abstract][Full Text] [Related]
35. The functional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor.
Schultz J; Lorenz P; Ibrahim SM; Kundt G; Gross G; Kunz M
Mol Carcinog; 2009 Jan; 48(1):14-23. PubMed ID: 18459127
[TBL] [Abstract][Full Text] [Related]
36. Tumorigenic N-terminal deletions of c-Myb modulate DNA binding, transactivation, and cooperativity with C/EBP.
Oelgeschläger M; Kowenz-Leutz E; Schreek S; Leutz A; Lüscher B
Oncogene; 2001 Nov; 20(50):7420-4. PubMed ID: 11704872
[TBL] [Abstract][Full Text] [Related]
37. Adenovirus-mediated expression of dominant negative c-myb induces apoptosis in head and neck cancer cells and inhibits tumor growth in animal model.
Kim SY; Yang YS; Hong KH; Jang KY; Chung MJ; Lee DY; Lee JC; Yi HK; Nam SY; Hwang PH
Oral Oncol; 2008 Apr; 44(4):383-92. PubMed ID: 17690006
[TBL] [Abstract][Full Text] [Related]
38. A decrease in miR-150 regulates the malignancy of pancreatic cancer by targeting c-Myb and MUC4.
Yang K; He M; Cai Z; Ni C; Deng J; Ta N; Xu J; Zheng J
Pancreas; 2015 Apr; 44(3):370-9. PubMed ID: 25522282
[TBL] [Abstract][Full Text] [Related]
39. MYB promotes the growth and metastasis of salivary adenoid cystic carcinoma.
Xu LH; Zhao F; Yang WW; Chen CW; Du ZH; Fu M; Ge XY; Li SL
Int J Oncol; 2019 May; 54(5):1579-1590. PubMed ID: 30896785
[TBL] [Abstract][Full Text] [Related]
40. c-Myb regulates NOX1/p38 to control survival of colorectal carcinoma cells.
Pekarčíková L; Knopfová L; Beneš P; Šmarda J
Cell Signal; 2016 Aug; 28(8):924-36. PubMed ID: 27107996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
